Major upper gastrointestinal bleeding and the use of calcium channel blockers

Lancet

Volumn 353, Issue 9152, 1999, Pages 559-

  Kelly, Judith P ^a   Laszlo, Andras ^b   Kaufman, David W ^b   Sundstrom, Anders ^b   Shapiro, Samuel ^b  

^a BOSTON UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; NIFEDIPINE; VERAPAMIL;

CONTROLLED STUDY; DIGESTIVE SYSTEM HEMORRHAGE; ENDOSCOPY; HEART DISEASE; HUMAN; HUNGARY; HYPERTENSION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RISK; RISK BENEFIT ANALYSIS; SHORT SURVEY; SWEDEN; UNITED STATES;

EID: 0344820719     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)05202-7     Document Type: Article

References (4)

1. Pahor M, Guralnik JM, Furberg CD, Carbonin P, Havlik RJ. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 1996; 347: 1061-65.
2. Smalley WE, Ray WA, Daugherty JR, Griffin MR. No association between calcium channel blocker use and confirmed bleeding peptic ulcer disease. Am J Epidemiol 1998; 148: 350-54.
3. Suissa S, Bourgault C, Barkun A, Sheehy O, Ernst P. Antihypertensive drugs and the risk of gastrointestinal bleeding. Am J Med 1998; 105: 230-35.
4. Kaufman DW, Kelly JP, Sheehan JE, et al. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993; 53: 485-94.